A new study has revealed that certain bone marrow cells may absorb more radiation during radiopharmaceutical therapy (RPT) than previously believed. This finding could explain unexpected side effects like reduced blood cell counts that some neuroendocrine cancer patients experience. Radiopharmaceutical therapy has become a promising cancer treatment, using imaging to guide therapy and adjust doses … Continue reading NETRF-funded Research Highlights Risks in Radiopharmaceutical Therapy for NETs